Mural Oncology Plc's market cap is currently $36.04M. The company's EPS TTM is $-2.78; its P/E ratio is ―; Mural Oncology Plc is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
